Author:
Reijnders Margot R F,Janowski Robert,Alvi Mohsan,Self Jay E,van Essen Ton J,Vreeburg Maaike,Rouhl Rob P W,Stevens Servi J C,Stegmann Alexander P A,Schieving Jolanda,Pfundt Rolph,van Dijk Katinke,Smeets Eric,Stumpel Connie T R M,Bok Levinus A,Cobben Jan Maarten,Engelen Marc,Mansour Sahar,Whiteford Margo,Chandler Kate E,Douzgou Sofia,Cooper Nicola S,Tan Ene-Choo,Foo Roger,Lai Angeline H M,Rankin Julia,Green Andrew,Lönnqvist Tuula,Isohanni Pirjo,Williams Shelley,Ruhoy Ilene,Carvalho Karen S,Dowling James J,Lev Dorit L,Sterbova Katalin,Lassuthova Petra,Neupauerová Jana,Waugh Jeff L,Keros Sotirios,Clayton-Smith Jill,Smithson Sarah F,Brunner Han G,van Hoeckel Ceciel,Anderson Mel,Clowes Virginia E,Siu Victoria Mok,DDD study The,Selber Paulo,Leventer Richard J,Nellaker Christoffer,Niessing Dierk,Hunt David,Baralle Diana
Abstract
BackgroundDe novo mutations in PURA have recently been described to cause PURA syndrome, a neurodevelopmental disorder characterised by severe intellectual disability (ID), epilepsy, feeding difficulties and neonatal hypotonia.ObjectivesTo delineate the clinical spectrum of PURA syndrome and study genotype-phenotype correlations.MethodsDiagnostic or research-based exome or Sanger sequencing was performed in individuals with ID. We systematically collected clinical and mutation data on newly ascertained PURA syndrome individuals, evaluated data of previously reported individuals and performed a computational analysis of photographs. We classified mutations based on predicted effect using 3D in silico models of crystal structures of Drosophila-derived Pur-alpha homologues. Finally, we explored genotype-phenotype correlations by analysis of both recurrent mutations as well as mutation classes.ResultsWe report mutations in PURA (purine-rich element binding protein A) in 32 individuals, the largest cohort described so far. Evaluation of clinical data, including 22 previously published cases, revealed that all have moderate to severe ID and neonatal-onset symptoms, including hypotonia (96%), respiratory problems (57%), feeding difficulties (77%), exaggerated startle response (44%), hypersomnolence (66%) and hypothermia (35%). Epilepsy (54%) and gastrointestinal (69%), ophthalmological (51%) and endocrine problems (42%) were observed frequently. Computational analysis of facial photographs showed subtle facial dysmorphism. No strong genotype-phenotype correlation was identified by subgrouping mutations into functional classes.ConclusionWe delineate the clinical spectrum of PURA syndrome with the identification of 32 additional individuals. The identification of one individual through targeted Sanger sequencing points towards the clinical recognisability of the syndrome. Genotype-phenotype analysis showed no significant correlation between mutation classes and disease severity.
Funder
National Medical Research Council, Ministry of Health, Republic of Singapore
Health Innovation Challenge Fund
Deutsche Forschungsgemeinschaft
MH CR AZV
Melbourne Children’s Clinician Scientist Fellowship
Newlife Foundation for Disabled Children
Subject
Genetics(clinical),Genetics